InsidersTradesSigma
Follow the Scientific Industries INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Scientific Industries INC has logged 49 reports. Market capitalisation: €9.8m. The latest transaction was filed on 8 September 2026 (Acquisition). Among the most active insiders: MOORE JOHN A. The full history is free.
49
Insider Decl.
n/a
Thresholds
€2m
28 ops.
Buy Volume
€135,184
13 ops.
Sell Volume
52Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,311 of 29,064 companies
11.5
score / 100
Value8
Quality16
FCF yld-84%
Earn yld-12%
EV/EBITDA·
ROE-75%
Gross mgn26%
Net mgn-24%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2026
Declarations49 total
5,000 shares@ US$0.760.038% mcap0.9% of flowCommon StockSEC:0001182944-26-000006:0
Canonical exit: 18 Nov 2026 (T+90)
14,700 shares@ US$0.71120.13% mcap2.6% of flowCommon StockSEC:0001182944-26-000005:0
Canonical exit: 18 Nov 2026 (T+90)
9,000 shares@ US$0.581.6% of flowCommon StockSEC:0001182944-26-000003:0
Canonical exit: 21 Jun 2026 (T+90)
1,000 shares@ US$0.650.2% of flowCommon StockSEC:0001182944-26-000002:0
Canonical exit: 20 May 2026 (T+90)
6,500 shares@ US$0.53150.9% of flowCommon StockSEC:0001182944-25-000009:0
Canonical exit: 17 Mar 2026 (T+90)
11,700 shares@ US$0.54351.6% of flowCommon StockSEC:0001182944-25-000008:0
Canonical exit: 17 Mar 2026 (T+90)
20,000 shares@ US$0.60483.0% of flowCommon StockSEC:0001182944-25-000007:0
Canonical exit: 5 Mar 2026 (T+90)
15,000 shares@ US$1.0023.9% of flowCommon StockSEC:0001238884-25-000005:0
9,599 shares@ US$0.641.6% of flowCommon StockSEC:0001182944-25-000005:0
Canonical exit: 15 Dec 2025 (T+90)
5,800 shares@ US$0.701.1% of flowCommon StockSEC:0001182944-25-000006:0
Canonical exit: 16 Dec 2025 (T+90)
10,000 shares@ US$1.0049.4% of flowCommon StockSEC:0002021300-25-000003:0
30,000 shares@ US$1.008.2% of flowCommon StockSEC:0001182944-25-000004:0
10,000 shares@ US$1.0050.6% of flowCommon StockSEC:0002021300-25-000002:0
Canonical exit: 17 Jul 2025 (T+90)
35,000 shares@ US$1.0010.8% of flowCommon StockSEC:0001182944-25-000002:0
Canonical exit: 17 Jul 2025 (T+90)
15,000 shares@ US$1.0032.1% of flowCommon StockSEC:0001238884-25-000001:0
Canonical exit: 17 Jul 2025 (T+90)
250,000 shares@ US$1.0014.1% of flowCommon StockSEC:0001781002-25-000004:0
Canonical exit: 17 Jul 2025 (T+90)
7,000 shares@ US$0.9652.2% of flowCommon StockSEC:0001182944-24-000008:0
Canonical exit: 29 Jan 2025 (T+90)
15,000 shares@ US$2.0067.9% of flowCommon StockSEC:0001238884-24-000003:0
Canonical exit: 12 Mar 2024 (T+90)
79,245 shares@ US$2.00100.0% of flowCommon StockSEC:0001557341-24-000003:0
Canonical exit: 18 Mar 2024 (T+90)
7,100 shares@ US$1.5273.6% of flowCommon StockSEC:0001182944-24-000006:0
Canonical exit: 11 Sept 2024 (T+90)
20,400 shares@ US$2.0013.2% of flowCommon StockSEC:0001182944-24-000004:0
Canonical exit: 18 Mar 2024 (T+90)
11 shares@ US$2.000.2% of flowCommon StockSEC:0001182944-24-000002:0
Canonical exit: 16 Apr 2024 (T+90)
2,030 shares@ US$2.001.3% of flowCommon stockSEC:0001182944-24-000005:0
Canonical exit: 19 Mar 2024 (T+90)
26,100 shares@ US$2.0017.1% of flowCommon stockSEC:0001182944-24-000003:0
Canonical exit: 12 Mar 2024 (T+90)
27,530 shares@ US$2.0029.9% of flowCommon StockSEC:0001776356-24-000001:0
Canonical exit: 12 Mar 2024 (T+90)
25 of 49 declarations
关于 Scientific Industries INC
Scientific Industries Inc. (SCND) 是一家总部位于美国的生命科学技术公司，专注于实验室仪器、药房自动化和生物加工。尽管您的提示提及纽约证券交易所/纳斯达克，但审查的公开资料显示，其股票目前在OTCQB报价，而非在纽约证券交易所或纳斯达克上市。该公司总部位于美国纽约州波西米亚，并在欧洲设有运营机构。Scientific Industries 成立于1954年，在台式实验室设备领域建立了其传统，之后于2025年进行了重大的战略调整，转向药房自动化和生物加工两大增长平台。([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai)) 历史上，该公司以其混合和搅拌产品（尤其是Vortex-Genie系列）以及以Torbal品牌销售的精密称重和测量产品而闻名。这一传统使Scientific Industries在大学、医院、制药和工业实验室中占据了持久的地位。即使在2025年8月出售其Genie部门后，该公司在精密科学工具和工作流支持实验室技术方面仍保持着强大的品牌形象。([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai)) 如今，Scientific Industries围绕两个核心运营主题进行组织。第一个是药房自动化，由VIVID®自动药丸计数系统和相关工作站解决方案主导，旨在提高配药速度、准确性和合规性。第二个是生物加工，通过Scientific Bioprocessing (SBI)及其DOTS®平台实现，该平台旨在在开发早期生成高密度实验数据，并帮助研究人员降低放大风险。该公司还强调Torbal旗下的精密天平、实验室天平和水分分析仪，以支持其在受监管科学工作流中的广泛存在。([scientificindustries.com](https://www.scientificindustries.com/pages/about-us?utm_source=openai)) 从竞争角度来看，Scientific Industries最好被视为利基专业公司，而非综合性工业巨头。其价值主张在于应用特定产品、嵌入式工作流智能以及服务于对准确性、可重复性和数据质量有要求的受监管终端市场的能力。在生物加工领域，其差异化优势在于在开发周期早期提供更丰富、更具可操作性的数据；在药房自动化领域，重点在于合规性和运营效率。该公司还指出其长期建立的客户基础和专利技术，这些可以支持客户留存和产品信誉，尽管其规模相对于大型同行较小。([scientificindustries.com](https://www.scientificindustries.com/pages/about-us?utm_source=openai)) 从地理上看，Scientific Industries仍以美国为中心，总部位于纽约州波西米亚，其SEC文件中还提及了匹兹堡和德国的运营参考。其产品通过分销商和直销渠道在全球销售，具体取决于产品系列。近期公司里程碑包括2025年4月SBI获得新资金、2024财年和2025年第一季度报告，以及2025年8月以约9.6 million美元现金（外加潜在的盈利分成）剥离Genie部门，这极大地强化了公司对数据驱动平台的战略重点。([sec.gov](https://www.sec.gov/Archives/edgar/data/87802/000165495425003699/scnd_10k.htm?utm_source=openai))
